Observational studyPathogens (Basel, Switzerland)2026
Coverage, Timing, Safety, and Determinants of Neonatal Intensive Care Unit Admission in Newborns Receiving Nirsevimab Prophylaxis for Respiratory Syncytial Virus.
Maria Costantino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.